vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and RADIANT LOGISTICS, INC (RLGT). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $232.1M, roughly 1.2× RADIANT LOGISTICS, INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 2.3%, a 94.0% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs -12.3%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 12.1%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Radiant Logistics, Inc. is a leading third-party logistics provider offering end-to-end supply chain solutions, domestic and international freight forwarding, warehousing, and last-mile delivery services. It primarily serves North American markets, with key client segments including retail, manufacturing, e-commerce, and industrial sectors, helping businesses optimize logistics workflows and cut operational costs.
ACAD vs RLGT — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $232.1M |
| Net Profit | $273.6M | $5.3M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 3.2% |
| Net Margin | 96.3% | 2.3% |
| Revenue YoY | 9.4% | -12.3% |
| Net Profit YoY | 90.3% | -18.0% |
| EPS (diluted) | $1.61 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $232.1M | ||
| Q3 25 | $278.6M | $226.7M | ||
| Q2 25 | $264.6M | $220.6M | ||
| Q1 25 | $244.3M | $214.0M | ||
| Q4 24 | $259.6M | $264.5M | ||
| Q3 24 | $250.4M | $203.6M | ||
| Q2 24 | $242.0M | $206.0M | ||
| Q1 24 | $205.8M | $184.6M |
| Q4 25 | $273.6M | $5.3M | ||
| Q3 25 | $71.8M | $1.3M | ||
| Q2 25 | $26.7M | $4.9M | ||
| Q1 25 | $19.0M | $2.5M | ||
| Q4 24 | $143.7M | $6.5M | ||
| Q3 24 | $32.8M | $3.4M | ||
| Q2 24 | $33.4M | $4.8M | ||
| Q1 24 | $16.6M | $-703.0K |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | 3.2% | ||
| Q3 25 | 12.8% | 0.9% | ||
| Q2 25 | 12.2% | 2.4% | ||
| Q1 25 | 7.9% | 1.6% | ||
| Q4 24 | 59.1% | 3.3% | ||
| Q3 24 | 12.6% | 1.9% | ||
| Q2 24 | 12.6% | 2.4% | ||
| Q1 24 | 7.4% | -0.5% |
| Q4 25 | 96.3% | 2.3% | ||
| Q3 25 | 25.8% | 0.6% | ||
| Q2 25 | 10.1% | 2.2% | ||
| Q1 25 | 7.8% | 1.2% | ||
| Q4 24 | 55.4% | 2.4% | ||
| Q3 24 | 13.1% | 1.7% | ||
| Q2 24 | 13.8% | 2.3% | ||
| Q1 24 | 8.0% | -0.4% |
| Q4 25 | $1.61 | $0.11 | ||
| Q3 25 | $0.42 | $0.03 | ||
| Q2 25 | $0.16 | $0.10 | ||
| Q1 25 | $0.11 | $0.05 | ||
| Q4 24 | $0.86 | $0.13 | ||
| Q3 24 | $0.20 | $0.07 | ||
| Q2 24 | $0.20 | $0.11 | ||
| Q1 24 | $0.10 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $31.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $229.8M |
| Total Assets | $1.6B | $439.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $31.9M | ||
| Q3 25 | $258.0M | $28.1M | ||
| Q2 25 | $253.6M | $22.9M | ||
| Q1 25 | $217.7M | $19.0M | ||
| Q4 24 | $319.6M | $19.9M | ||
| Q3 24 | $155.1M | $10.4M | ||
| Q2 24 | $177.1M | $24.9M | ||
| Q1 24 | $204.7M | $31.2M |
| Q4 25 | $1.2B | $229.8M | ||
| Q3 25 | $917.3M | $225.7M | ||
| Q2 25 | $822.4M | $226.0M | ||
| Q1 25 | $765.2M | $218.2M | ||
| Q4 24 | $732.8M | $214.4M | ||
| Q3 24 | $577.2M | $212.4M | ||
| Q2 24 | $516.7M | $209.4M | ||
| Q1 24 | $464.0M | $206.0M |
| Q4 25 | $1.6B | $439.4M | ||
| Q3 25 | $1.3B | $445.3M | ||
| Q2 25 | $1.2B | $426.8M | ||
| Q1 25 | $1.1B | $414.5M | ||
| Q4 24 | $1.2B | $386.8M | ||
| Q3 24 | $976.9M | $375.3M | ||
| Q2 24 | $914.1M | $371.2M | ||
| Q1 24 | $855.1M | $364.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $12.4M |
| Free Cash FlowOCF − Capex | — | $11.6M |
| FCF MarginFCF / Revenue | — | 5.0% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | -0.18× | 2.33× |
| TTM Free Cash FlowTrailing 4 quarters | — | $8.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $12.4M | ||
| Q3 25 | $74.3M | $2.5M | ||
| Q2 25 | $64.0M | $3.1M | ||
| Q1 25 | $20.3M | $-5.7M | ||
| Q4 24 | $40.4M | $15.7M | ||
| Q3 24 | $63.2M | $205.0K | ||
| Q2 24 | $25.0M | $1.3M | ||
| Q1 24 | $29.1M | $3.9M |
| Q4 25 | — | $11.6M | ||
| Q3 25 | $73.9M | $977.0K | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $-6.4M | ||
| Q4 24 | — | $14.1M | ||
| Q3 24 | $63.2M | $-1.9M | ||
| Q2 24 | — | $-185.0K | ||
| Q1 24 | — | $1.8M |
| Q4 25 | — | 5.0% | ||
| Q3 25 | 26.5% | 0.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | -3.0% | ||
| Q4 24 | — | 5.3% | ||
| Q3 24 | 25.2% | -0.9% | ||
| Q2 24 | — | -0.1% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | 0.0% | 1.0% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 1.2% |
| Q4 25 | -0.18× | 2.33× | ||
| Q3 25 | 1.03× | 1.90× | ||
| Q2 25 | 2.40× | 0.63× | ||
| Q1 25 | 1.07× | -2.26× | ||
| Q4 24 | 0.28× | 2.43× | ||
| Q3 24 | 1.93× | 0.06× | ||
| Q2 24 | 0.75× | 0.26× | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
RLGT
| Transferred Over Time | $201.2M | 87% |
| Other | $25.0M | 11% |
| Value Added Services | $4.2M | 2% |
| Transferred At Point In Time | $1.8M | 1% |
